Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 29 September 2026 (Including F&O)

  • September 28, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow, 29 September 2026 (Including F&O)

Nifty Pharma closed at 26,761.65, down 0.89% today. Nifty 50 fell 1.56%. India VIX rose 12.17%.

Quick Answer

The nifty pharma prediction for tomorrow is cautious for 29 September 2026, with Apollo Hospitals Enterprise as the key constituent to track, tracking broader Nifty 50 direction and F&O positioning into Tuesday’s session.

The nifty pharma prediction for tomorrow is in focus after a Monday session in which the broader Nifty 50 fell 1.56 percent to 22,780.25, as renewed US-Iran tensions, Brent crude above 106 dollars, a US 10-year Treasury yield near 5.17 percent and steady foreign selling pushed India VIX up 12.17 percent to 13.64 and the Nifty 50 below 23,000, its lowest in about six months. Pharma stocks fell less than the broader market today, among the more defensive sectors

As with any nifty pharma prediction for tomorrow, the opening minutes of trade will confirm or challenge the levels discussed here.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 29 September 2026.

Click Here – Get Free Investment Predictions

This nifty pharma prediction for tomorrow is built from Monday’s verified market data, not speculation about what Tuesday will bring.

Table of Contents

Toggle
  • Today’s Sector Recap
  • Levels in Focus for Tomorrow
  • Nifty Pharma F&O Outlook for Tomorrow
  • Key Drivers for Tomorrow
  • Stocks to Watch for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Which stocks matter most for this sector’s outlook tomorrow?
    • Did Nifty Pharma hold up better than the market today?
    • Should traders take F&O positions based on this outlook?

Today’s Sector Recap

  • Apollo Hospitals Enterprise fell 0.33 percent, among the key movers in this space on 28 September 2026.
  • The broader Nifty 50 fell 1.56 percent, setting a cautious tone across most sectors.
  • India VIX rose 12.17 percent to 13.64, reversing the calm seen on Friday.

Levels in Focus for Tomorrow

Nifty Pharma traded between 26,748 and 27,041.90 on Monday, against a previous close of 27,003. Reclaiming 27,003 would be the first sign that selling pressure is easing, while a fresh break below 26,748 would put the day’s low back in play. Univest’s analysts treat these as reference points drawn from Monday’s trading range, not as targets.

Nothing in this nifty pharma prediction for tomorrow should be treated as a guarantee, only a working framework for Tuesday’s session.

Nifty Pharma F&O Outlook for Tomorrow

For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 29 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while continued volatility could see wider intraday swings.

Key Drivers for Tomorrow

  • Pharma stocks fell less than the broader market today, among the more defensive sectors
  • Crude oil surged 4.85 percent on MCX, driven by renewed US-Iran tensions and doubts over the Strait of Hormuz that pushed Brent back above 106 dollars a barrel, a theme relevant across the broader market.
  • Renewed US-Iran tensions, Brent crude above 106 dollars, a US 10-year Treasury yield near 5.17 percent and steady foreign selling pushed India VIX up 12.17 percent to 13.64 and the Nifty 50 below 23,000, its lowest in about six months.

This nifty pharma prediction for tomorrow should be read alongside the support and resistance levels detailed above.

Stocks to Watch for Tomorrow

Stock CMP Relevance
Apollo Hospitals Enterprise See Univest Screener Key Nifty Pharma constituent

Explore Nifty Pharma Stocks on Univest Screeners

Univest’s desk will revisit this nifty pharma prediction for tomorrow once Tuesday’s opening trade confirms direction.

Risks to This Prediction

  • A sharper than expected move in crude oil prices or US bond yields could shift sentiment across all sectors, including Nifty Pharma.
  • Stock-specific news flow in Apollo Hospitals Enterprise or other constituents could override the broader sector trend.
  • A further rise in India VIX could widen intraday ranges beyond the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces.

Traders relying on this nifty pharma prediction for tomorrow should still size positions to their own risk appetite.

Conclusion

The nifty pharma prediction for tomorrow leans cautious into 29 September 2026, with Apollo Hospitals Enterprise and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once Tuesday’s opening trade confirms direction.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

As with any nifty pharma prediction for tomorrow, the opening minutes of trade will confirm or challenge the levels discussed here.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is cautious, based on Apollo Hospitals Enterprise’s fall of 0.33 percent on 28 September 2026 and the broader Nifty 50 trend.

Which stocks matter most for this sector’s outlook tomorrow?

Ans. Apollo Hospitals Enterprise is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.

This nifty pharma prediction for tomorrow is built from Monday’s verified market data, not speculation about what Tuesday will bring.

Did Nifty Pharma hold up better than the market today?

Ans. Nifty Pharma fell 0.89 percent today, a smaller decline than the Nifty 50’s 1.56 percent fall.

Should traders take F&O positions based on this outlook?

Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given how sharply India VIX has moved this week.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply